
India has banned the manufacture and export of two highly addictive opioids – tapentadol and carisoprodol – after a report exposed their role in fueling a drug crisis in West Africa.
Aveo Pharmaceuticals, based in Mumbai, was found to be illegally exporting this combination of drugs to countries like Nigeria, Ghana and Ivory Coast.